rhein has been researched along with everolimus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Y; Fan, Z; Gao, F; Li, M; Li, R; Luo, WJ; Ou, L; Wei, PF | 1 |
1 other study(ies) available for rhein and everolimus
| Article | Year |
|---|---|
Synergistic anticancer effects of everolimus (RAD001) and Rhein on gastric cancer cells via phosphoinositide-3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway.
Topics: Animals; Anthraquinones; Cell Line, Tumor; Cell Survival; Drug Synergism; Everolimus; Female; Humans; Mice, SCID; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Stomach Neoplasms; TOR Serine-Threonine Kinases | 2022 |